GLP-1 Therapy
Semaglutide
the active ingredient in Ozempic® and Wegovy®.
A GLP-1 receptor agonist used, under physician supervision, to support weight management and blood sugar regulation.
How it works
Mimics the GLP-1 hormone your gut naturally releases, slowing gastric emptying and increasing feelings of fullness.
Who it's typically considered for
Adults with a BMI in the overweight or obese range, or with weight-related health conditions, after medical evaluation.
Common side effects
- — Nausea
- — Diarrhea or constipation
- — Fatigue
- — Injection-site reactions
Who should not take this
- — Pregnancy or breastfeeding
- — Personal or family history of medullary thyroid carcinoma or MEN2
- — Known hypersensitivity to semaglutide
i This is general information, not medical advice or a guarantee of eligibility or results. A licensed physician makes the final determination during your in-person evaluation.
